EXEL Exelixis, Inc. - Common Stock
$54.24
मूल्य · अग 19, 2026
मौलिकता इस प्रकार है अग 5, 2026
52W रेंज
$34–$58
86% of range
विश्लेषक रेटिंग
HOLD
26 analysts
मूल्य लक्ष्य
$53
P/E (TTM)
18.9
ROE
37.3%
शुद्ध लाभ मार्जिन
33.7%
Exelixis, Inc. - Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration (FDA) for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.
और पढ़ें
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration (FDA) for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.
History
Exelixis was founded in 1994; the scientific founders were Spyridon Artavanis–Tsakonas, at Yale at that time, and Corey Goodman and Gerry Rubin who were then at the University of California, Berkeley. George Scangos joined the company as CEO in 1996. The business plan was to use model organisms (fruit flies, nematodes, and zebrafish) and functional genomics to identify pathways and biological targets that could be exploited in the fields of agriculture and medicine. It eventually set up a subsidiary, Exelixis Plant Sciences, for the agricultural work.
By 2000, Exelixis had left the radical exploratory phase behind and became focused on drug discovery and had a chemical library of 4 million compounds. The company went public that year, after withdrawing its offering the week before; it raised $118 million in a down market.
In 2002, the company signed a broad alliance with GSK to discover new drugs in the fields of cancer, inflammatory diseases, and vascular conditions; GSK paid it $30 million in cash, bought $14 million in stock at twice the market rate, and committed to providing Exelixis with $90 million in research funding; it also offered loan financing of up to $85 million.
By 2002, the company had limited its internal efforts to cancer, and had settled its strategy on discovering and developing drugs that could inhibit targeted small sets of tyrosine kinases that are needed for cancer formation, growth, and metastasis. The sets of TKs had been identified by means of its prior functional genomics work. This approach was controversial at the time; most companies try to selectively target just one protein in their discovery efforts.
In 2006, Exelixis partnered with Daiichi Sankyo on compounds that targeted mineralocorticoid receptors; esaxerenone was part of this collaboration. In 2007, the company partnered its MEK inhibitor program with Genentech; cobimetinib (at that time XL-518) was part of this collaboration. Exelixis had filed an IND on XL-518 prior to the partnership, committed to funding and running the Phase I trial, and retained rights to co-market it in the US.
In 2008, the company partnered its lead cancer drug candidate, XL-184 (which would become called cabozantinib) and another cancer candidate, XL-281, with Bristol Myers Squibb; BMS returned the rights to XL-184 to Exelixis in 2010 and returned the rights to other drug candidate in 2011.
In 2010, Scangos departed as CEO to take over at Biogen and the company appointed Michael M. Morrissey as president and CEO; Morrissey had joined the company in 2000 as Vice President of Discovery Research. At that time the company had eight drugs in clinical trials.
Exelixis' first drug approval came in 2012, when cabozantinib was approved for medullary thyroid cancer, an orphan indication. It was approved in Europe in 2014.
Exelixis invested heavily in exploring cabozantinib in other cancers, betting the future of the company on the drug. In 2014 the drug failed a Phase III trial in prostate cancer, and the company laid off 70% of its employees.
In 2015, Genentech and Exelixis won FDA approval for cobimetinib for certain forms of melanoma.
In March 2016, Exelixis licensed to Ipsen worldwide rights (outside the US, Canada, and Japan) to market cabozantinib.
In April 2016, the FDA granted approval for marketing the tablet formulation as a second line treatment for kidney cancer and the same was approved in Europe in October of that year.
In December 2017, the FDA granted approval for the use of cabozantinib for first line treatment of kidney cancer and in 2018 approval for first-line treatment was approved in Europe.
Finance
Pricing
Cabometyx (cabozantinib)
In 2023, the Institute for Clinical and Economic Review (ICER) identified Cabometyx (cabozantinib) as one of five high-expenditure drugs that experienced significant net price increases without new clinical evidence to justify the hikes. Specifically, Cabometyx's wholesale acquisition cost rose by 7.5%, leading to an additional $86 million in costs to U.S. payers.
स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗
EXEL स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा
मूल्य
$54.24
मार्केट कैप
$13.76B
P/E (TTM)
18.9
EPS (TTM)
$2.78
राजस्व (TTM)
$2.32B
लाभांश प्रतिफल
—
ROE
37.3%
D/E ऋण/इक्विटी
—
52W रेंज
$34 – $58
EXEL स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें
Configure
10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान
राजस्व और शुद्ध आय
$2.32B
2016-12-31
→
2026-01-02
EPS
$2.78
2017-12-29
→
2026-01-02
फ्री कैश फ्लो
$876M
2017-12-29
→
2026-01-02
मार्जिन
33.7%
मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?
मेट्रिक
5Y रुझान
EXEL
सहकर्मी माध्यिका
P/E (TTM)
18.9
28.5
P/S (TTM)
5.9
20.1
P/B
6.4
12.9
Price / FCF (मूल्य / FCF)
15.7
—
लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC
मेट्रिक
5Y रुझान
EXEL
सहकर्मी माध्यिका
Operating Margin (परिचालन मार्जिन)
37.6%
—
Net Profit Margin (शुद्ध लाभ मार्जिन)
33.7%
-48.4%
ROA
27.0%
-28.4%
ROE
37.3%
-49.2%
वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती
मेट्रिक
5Y रुझान
EXEL
सहकर्मी माध्यिका
Current Ratio (वर्तमान अनुपात)
3.6
5.0
Quick Ratio (त्वरित अनुपात)
3.3
—
विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR
मेट्रिक
5Y रुझान
EXEL
सहकर्मी माध्यिका
Revenue YoY (राजस्व YoY)
7.0%
—
Revenue CAGR 3Y (राजस्व CAGR 3Y)
12.9%
—
Revenue CAGR 5Y (राजस्व CAGR 5Y)
18.6%
—
EPS YoY
58.0%
—
Net Income YoY (शुद्ध आय YoY)
50.1%
—
पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर
मेट्रिक
5Y रुझान
EXEL
सहकर्मी माध्यिका
EXEL विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड
खरीदें
26 विश्लेषक
- मजबूत खरीद 5 19.2%
- खरीदें 8 30.8%
- होल्ड 12 46.2%
- बेचें 1 3.8%
- मजबूत बिक्री 0 0.0%
12-महीने का मूल्य लक्ष्य
16 विश्लेषक · 2026-08-13
मध्यिका
$52.00
अभी
$54.24
निम्न
$41.00
उच्च
$66.00
मध्यिका लक्ष्य
$52.00
-4.1%
माध्य लक्ष्य
$52.94
-2.4%
Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि
औसत आश्चर्य
0.08%
| Period | EPS Actual | EPS अनुमान | आश्चर्य |
|---|---|---|---|
| 30 जून 2026 | $0.82 | $0.80 | 0.02% |
| 31 मार्च 2026 | $0.79 | $0.72 | 0.07% |
| 31 दिसमबर 2025 | $0.88 | $0.82 | 0.06% |
| 30 सितमबर 2025 | $0.69 | $0.63 | 0.06% |
| 30 जून 2025 | $0.65 | $0.57 | 0.08% |
| 31 मार्च 2025 | $0.55 | $0.37 | 0.18% |
सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी
| टिकर | मार्केट कैप | P/E | राजस्व YoY | शुद्ध मार्जिन | ROE | सकल मार्जिन |
|---|---|---|---|---|---|---|
| EXEL | $11.44B | 15.7 | 7.0% | 33.7% | 37.3% | — |
| UTHR | $21.27B | 17.5 | 10.6% | 41.9% | 18.7% | 87.9% |
| NBIX | $14.20B | 30.4 | 21.4% | 16.7% | 16.1% | — |
| BBIO | $14.90B | -20.2 | 126.3% | -146.0% | 41.2% | — |
| BMRN | $11.43B | 33.0 | 12.9% | 10.8% | 5.8% | — |
| ARWR | $4.68B | -3449.0 | 23258.2% | -0.20% | -0.50% | — |
| MDGL | $13.30B | -45.3 | 432.1% | -30.1% | -44.4% | — |
| HALO | $7.93B | 26.3 | 37.5% | 22.7% | 166.1% | — |
| PRAX | $7.43B | -21.9 | 249.5% | — | -47.3% | — |
| CYTK | $7.81B | -9.7 | 376.6% | -891.6% | 152.7% | — |
पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह
आय विवरण 16
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.32B | $2.17B | $1.83B | $1.61B | $1.43B | $988M | $968M | $854M | $452M | $191M | $37M | |
| Cost of Revenue | $84M | $76M | $73M | $58M | $53M | $36M | $33M | $26M | $15M | $7M | $4M | |
| R&D Expense | $825M | $910M | $1.04B | $892M | $694M | $548M | $337M | $182M | $112M | $96M | $96M | |
| SG&A Expense | $519M | $492M | $543M | $460M | $402M | $293M | $228M | $206M | $159M | $116M | $57M | |
| Operating Expenses | $1.45B | $1.56B | $1.66B | $1.41B | $1.15B | $877M | $598M | $415M | $287M | $220M | $159M | |
| Operating Income | $872M | $605M | $171M | $201M | $287M | $110M | $369M | $439M | $166M | $-28M | $-121M | |
| Interest Expense | · | · | · | · | · | · | $0 | $0 | $9M | $33M | $41M | |
| Other Non-op | $-198.0K | $-133.0K | $93.0K | $-197.0K | $-184.0K | $912.0K | $680.0K | $397.0K | $-4M | $5M | $-381.0K | |
| Pretax Income | · | · | · | · | · | $131M | $398M | $452M | $159M | $-70M | $-162M | |
| Income Tax | $159M | $160M | $50M | $52M | $63M | $19M | $77M | $-238M | $4M | $0 | $55.0K | |
| Net Income | $783M | $521M | $208M | $182M | $231M | $112M | $321M | $690M | $154M | $-70M | $-162M | |
| EPS (Basic) | $2.88 | $1.80 | $0.65 | $0.57 | $0.73 | $0.36 | $1.06 | $2.32 | $0.52 | · | $-0.77 | |
| EPS (Diluted) | $2.78 | $1.76 | $0.65 | $0.56 | $0.72 | $0.35 | $1.02 | $2.21 | $0.49 | · | $-0.77 | |
| Shares (Basic) | 271,567,000 | 290,030,000 | 318,151,000 | 321,526,000 | 314,884,000 | 308,271,000 | 302,584,000 | 297,892,000 | 293,588,000 | · | 209,227,000 | |
| Shares (Diluted) | 281,863,000 | 296,132,000 | 321,464,000 | 324,556,000 | 322,359,000 | 318,001,000 | 315,009,000 | 312,803,000 | 312,003,000 | · | 209,227,000 | |
| EBITDA | $901M | $633M | $197M | $222M | $300M | $119M | $378M | $444M | $167M | · | · |
बैलेंस शीट 27
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $482M | $217M | $263M | $501M | $647M | $319M | $267M | $315M | $183M | $152M | $142M | |
| Short-term Investments | $577M | $894M | $732M | $807M | $820M | $887M | $586M | $379M | $205M | $268M | · | |
| Receivables | $287M | $265M | $237M | $215M | $283M | $161M | $119M | $163M | $77M | $40M | · | |
| Inventory | $22M | $22M | $17M | $33M | $27M | $21M | $13M | $10M | $7M | $3M | · | |
| Prepaid Expense | $76M | $68M | $68M | $62M | $58M | $57M | $27M | $31M | $9M | $5M | · | |
| Current Assets | $1.44B | $1.47B | $1.32B | $1.62B | $1.83B | $1.45B | $1.01B | $897M | $485M | $469M | · | |
| PP&E (Net) | $99M | $119M | $129M | $111M | $104M | $67M | $49M | $51M | $26M | $2M | · | |
| PP&E (Gross) | $231M | $220M | $209M | $171M | $145M | $102M | $74M | $68M | $49M | $27M | · | |
| Accum. Depreciation | $132M | $101M | $80M | $61M | $41M | $35M | $26M | $17M | $23M | $25M | · | |
| Goodwill | $64M | $64M | $64M | $64M | $64M | $64M | $64M | $64M | $64M | $64M | · | |
| Other Non-current Assets | · | · | · | · | $131M | $73M | $53M | $8M | $12M | $1M | · | |
| Total Assets | $2.84B | $2.95B | $2.94B | $3.07B | $2.62B | $2.14B | $1.89B | $1.42B | $655M | $596M | · | |
| Accounts Payable | $30M | $38M | $34M | $33M | $24M | $24M | $12M | $11M | $10M | $7M | · | |
| Short-term Debt | · | · | · | · | · | · | · | · | $0 | $80M | · | |
| Current Liabilities | $406M | $404M | $394M | $324M | $338M | $205M | $143M | $105M | $115M | $269M | · | |
| Capital Leases | $173M | $191M | $190M | $190M | $51M | $49M | $48M | $12M | $15M | · | · | |
| Other Non-current Liabilities | $104M | $109M | $94M | $69M | $8M | $721.0K | $2M | $1M | $2M | $541.0K | · | |
| Total Liabilities | $683M | $703M | $678M | $583M | $406M | $258M | $200M | $135M | $370M | $506M | · | |
| Long-term Debt | · | · | · | · | · | · | · | · | $0 | $189M | · | |
| Total Debt | · | · | · | · | · | · | · | · | $0 | · | · | |
| Common Stock | $262.0K | $282.0K | $303.0K | $324.0K | $319.0K | $312.0K | $305.0K | $300.0K | $296.0K | $290.0K | · | |
| Paid-in Capital | $2.23B | $2.34B | $2.44B | $2.54B | $2.43B | $2.32B | $2.24B | $2.17B | $2.11B | $2.07B | · | |
| Retained Earnings | $-77M | $-99M | $-173M | $-34M | $-217M | $-448M | $-559M | $-880M | $-1.83B | $-1.98B | · | |
| AOCI | $3M | $-1M | $-4M | $-15M | $-758.0K | $4M | $3M | $-701.0K | $-347.0K | $-416.0K | · | |
| Stockholders' Equity | $2.16B | $2.24B | $2.26B | $2.49B | $2.21B | $1.88B | $1.69B | $1.29B | $285M | $89M | $-141M | |
| Liabilities + Equity | $2.84B | $2.95B | $2.94B | $3.07B | $2.62B | $2.14B | $1.89B | $1.42B | $655M | $596M | · | |
| Shares Outstanding | 262,483,000 | 281,732,000 | 302,793,000 | 323,951,000 | 318,842,000 | 311,627,000 | 304,831,000 | 299,876,000 | 296,209,000 | 289,923,798 | 227,960,943 |
नकदी प्रवाह 17
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $29M | $29M | $26M | $21M | $14M | $9M | $8M | $5M | $1M | $1M | $1M | |
| Stock-based Comp | $113M | $94M | $106M | $108M | $120M | $105M | $57M | $41M | $24M | $23M | $22M | |
| Deferred Tax | $126M | $-59M | $-133M | $-60M | $47M | $15M | $71M | $-244M | $0 | $0 | $0 | |
| Restructuring | $21M | $34M | $0 | $0 | · | · | · | $0 | $-32.0K | $63M | $1M | |
| Other Non-cash | $-167M | $116M | $127M | $112M | $-10M | $-32M | $70M | $-76M | $-14M | · | · | |
| Operating Cash Flow | $884M | $700M | $333M | $363M | $401M | $209M | $527M | $416M | $166M | $206M | $-141M | |
| CapEx | $8M | $28M | $40M | $28M | $54M | $30M | $13M | $33M | $21M | $2M | $447.0K | |
| Investing Cash Flow | $350M | $-117M | $-27M | $-524M | $-43M | $-131M | $-587M | $-298M | $37M | $-216M | $50M | |
| Net Debt Issued | · | · | · | · | · | · | $0 | $0 | $-186M | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | $0 | $0 | $146M | |
| Stock Repurchased | $948M | $652M | $550M | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | $-948M | $-652M | $-550M | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | $-970M | $-629M | $-546M | $586.0K | $-15M | $-25M | $13M | $10M | $-170M | $20M | $152M | |
| Net Change in Cash | $265M | $-46M | $-240M | $-161M | $343M | $53M | $-48M | $128M | $32M | $10M | $61M | |
| Taxes Paid | $155M | $170M | $186M | $128M | $13M | $4M | $8M | $11M | $538.0K | · | · | |
| Free Cash Flow | $876M | $672M | $293M | $335M | $337M | $179M | $514M | $382M | $144M | · | · | |
| Levered FCF | · | · | · | · | · | · | $514M | $382M | $136M | · | · |
लाभप्रदता 7
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 37.6% | 27.9% | 9.3% | 12.5% | 20.0% | 11.1% | 38.2% | 51.4% | 36.7% | · | · | |
| Net Margin | 33.7% | 24.0% | 11.3% | 11.3% | 16.1% | 11.3% | 33.2% | 80.8% | 34.1% | · | · | |
| Pretax Margin | · | · | · | · | · | 13.2% | 41.1% | 52.9% | 35.0% | · | · | |
| EBITDA Margin | 38.8% | 29.2% | 10.7% | 13.8% | 20.9% | 12.1% | 39.0% | 52.0% | 36.9% | · | · | |
| ROA | 27.0% | 17.7% | 6.9% | 6.4% | 9.7% | 5.6% | 19.4% | 66.4% | 24.7% | · | · | |
| ROE | 37.3% | 23.1% | 9.0% | 7.3% | 10.7% | 6.0% | 19.5% | 62.6% | 82.4% | · | · | |
| ROIC | · | · | · | · | · | 5.0% | 17.7% | 52.0% | 56.6% | · | · |
तरलता और शोधन क्षमता 4
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.6 | 3.6 | 3.3 | 5.0 | 5.4 | 7.1 | 7.1 | 8.5 | 4.2 | · | · | |
| Quick Ratio | 3.3 | 3.4 | 3.1 | 4.7 | 5.2 | 6.7 | 6.8 | 8.1 | 4.1 | · | · | |
| Debt / Equity | · | · | · | · | · | · | · | · | 0.0 | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | 19.1 | · | · |
दक्षता 3
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 | 0.8 | 0.7 | · | · | |
| Inventory Turnover | 3.8 | 3.8 | 2.9 | 1.9 | 2.2 | 2.1 | 2.9 | 3.2 | 3.0 | · | · | |
| Receivables Turnover | 8.4 | 8.6 | 8.1 | 6.5 | 6.5 | 7.1 | 6.9 | 9.8 | 7.4 | · | · |
विकास दरें 9
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 7.0% | 18.5% | 13.6% | 12.3% | 45.3% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.9% | 14.8% | 22.8% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 18.6% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 58.0% | 170.8% | 16.1% | -22.2% | 105.7% | · | · | · | · | · | · | |
| EPS CAGR 3Y | 70.6% | 34.7% | 22.9% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 51.3% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 50.1% | 150.9% | 14.0% | -21.1% | 106.7% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 62.5% | 31.1% | 22.9% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 47.6% | · | · | · | · | · | · | · | · | · | · |
मूल्यांकन (TTM) 14
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.32B | $2.17B | $1.83B | $1.61B | $1.43B | $988M | $968M | $854M | $452M | · | $37M | |
| Net Income TTM | $783M | $521M | $208M | $182M | $231M | $112M | $321M | $690M | $154M | · | $-162M | |
| Market Cap | $11.44B | $9.57B | $7.26B | $5.20B | $5.83B | $6.25B | $5.19B | $5.83B | $9.00B | · | · | |
| Enterprise Value | · | · | · | · | · | · | · | · | $8.62B | · | · | |
| P/E | 15.7 | 19.3 | 36.9 | 28.6 | 25.4 | 57.3 | 16.7 | 8.8 | 62.0 | · | -7.3 | |
| P/S | 4.9 | 4.4 | 4.0 | 3.2 | 4.1 | 6.3 | 5.4 | 6.8 | 19.9 | · | · | |
| P/B | 5.3 | 4.3 | 3.2 | 2.1 | 2.6 | 3.3 | 3.1 | 4.5 | 31.6 | · | · | |
| P / Tangible Book | 5.5 | 4.4 | 3.3 | 2.1 | 2.7 | 3.4 | · | · | · | · | · | |
| P / Cash Flow | 12.9 | 13.7 | 21.8 | 14.3 | 14.5 | 29.9 | 9.8 | 14.0 | 54.4 | · | · | |
| P / FCF | 13.1 | 14.3 | 24.8 | 15.5 | 17.3 | 35.0 | 10.1 | 15.2 | 62.3 | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | 51.6 | · | · | |
| EV / FCF | · | · | · | · | · | · | · | · | 59.6 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | 19.0 | · | · | |
| Earnings Yield | 6.4% | 5.2% | 2.7% | 3.5% | 3.9% | 1.7% | 6.0% | 11.4% | 1.6% | · | -13.7% |
आय विवरण 14
| मेट्रिक | रुझान | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2024 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $629M | $611M | $718M | $598M | $568M | $555M | $818M | $540M | $637M | $425M | $480M | $472M | $470M | $409M | $424M | $412M | |
| Cost of Revenue | $21M | $20M | $27M | $19M | $19M | $19M | $25M | $17M | $18M | $21M | $22M | $19M | $18M | $14M | $16M | $15M | |
| R&D Expense | $212M | $200M | $164M | $199M | $200M | $212M | $111M | $223M | $211M | $228M | $245M | $333M | $233M | $234M | $337M | $199M | |
| SG&A Expense | $148M | $140M | $161M | $124M | $135M | $137M | $81M | $112M | $132M | $114M | $131M | $138M | $142M | $131M | $119M | $115M | |
| Operating Expenses | $380M | $359M | $287M | $361M | $355M | $369M | $303M | $403M | $361M | $396M | $398M | $490M | $392M | $380M | $472M | $329M | |
| Operating Income | $248M | $251M | $431M | $237M | $214M | $187M | $516M | $136M | $276M | $29M | $82M | $-18M | $78M | $29M | $-48M | $83M | |
| Other Non-op | $54.0K | $219.0K | $207.0K | $-49.0K | $50.0K | $-245.0K | $-363.0K | $-29.0K | $-287.0K | $-89.0K | $-137.0K | $289.0K | $-5.0K | $-54.0K | $-337.0K | $-69.0K | |
| Income Tax | $51M | $57M | $43M | $59M | $46M | $46M | $128M | $37M | $67M | $12M | $18M | $5M | $19M | $8M | $-1M | $19M | |
| Net Income | $212M | $210M | $401M | $194M | $185M | $160M | $399M | $118M | $226M | $37M | $86M | $1M | $81M | $40M | $-30M | $73M | |
| EPS (Basic) | $0.85 | $0.81 | $1.57 | $0.72 | $0.68 | $0.57 | $1.43 | $0.41 | $0.78 | $0.12 | $0.28 | $0.00 | $0.25 | $0.12 | $-0.09 | $0.23 | |
| EPS (Diluted) | $0.82 | $0.79 | $1.49 | $0.69 | $0.65 | $0.55 | $1.39 | $0.40 | $0.77 | $0.12 | $0.28 | $0.00 | $0.25 | $0.12 | $-0.09 | $0.23 | |
| Shares (Basic) | 250,808,000 | 258,329,000 | -604,028,000 | 268,421,000 | 272,583,000 | 278,804,000 | -674,091,000 | 285,622,000 | 289,216,000 | 300,757,000 | -645,970,000 | 315,496,000 | 324,205,000 | 324,420,000 | 577,000 | 322,148,000 | |
| Shares (Diluted) | 259,675,000 | 267,322,000 | -609,119,000 | 278,535,000 | 284,393,000 | 288,177,000 | -676,699,000 | 291,478,000 | 293,974,000 | 305,530,000 | -651,367,000 | 319,247,000 | 327,305,000 | 326,279,000 | 136,000 | 325,066,000 | |
| EBITDA | $248M | $258M | · | $237M | $214M | $194M | · | $136M | $276M | $36M | · | $-18M | $78M | $36M | · | $83M |
बैलेंस शीट 24
| मेट्रिक | रुझान | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2024 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $281M | $226M | $482M | $376M | $164M | $184M | $217M | $258M | $198M | $260M | · | $397M | $464M | $541M | · | $675M | |
| Short-term Investments | $558M | $551M | $577M | $612M | $627M | $848M | $894M | $931M | $804M | $704M | · | $707M | $802M | $773M | · | $872M | |
| Receivables | $322M | $329M | $287M | $310M | $292M | $282M | $265M | $270M | $397M | $241M | · | $248M | $233M | $234M | · | $215M | |
| Inventory | $29M | $27M | $22M | $27M | $23M | $25M | $22M | $21M | $21M | $21M | · | $25M | $29M | $30M | · | $27M | |
| Prepaid Expense | $60M | $76M | $76M | $77M | $74M | $59M | $68M | $70M | $58M | $67M | · | $67M | $62M | $61M | · | $53M | |
| Current Assets | $1.25B | $1.21B | $1.44B | $1.40B | $1.18B | $1.40B | $1.47B | $1.55B | $1.48B | $1.29B | · | $1.44B | $1.59B | $1.64B | · | $1.84B | |
| PP&E (Net) | $93M | $96M | $99M | $105M | $110M | $115M | $119M | $124M | $130M | $127M | · | $121M | $115M | $116M | · | $108M | |
| PP&E (Gross) | · | · | $231M | · | · | · | $220M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $132M | · | · | · | $101M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $64M | $64M | $64M | $64M | $64M | $64M | $64M | $64M | $64M | $64M | · | $64M | $64M | $64M | · | $64M | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $280M | |
| Total Assets | $2.49B | $2.59B | $2.84B | $2.82B | $2.68B | $2.84B | $2.95B | $2.96B | $2.77B | $2.80B | · | $2.98B | $3.14B | $3.14B | · | $2.96B | |
| Accounts Payable | $39M | $24M | $30M | $25M | $26M | $43M | $38M | $59M | $29M | $26M | · | $26M | $26M | $33M | · | $31M | |
| Current Liabilities | $362M | $371M | $406M | $374M | $336M | $399M | $404M | $394M | $346M | $373M | · | $377M | $340M | $328M | · | $302M | |
| Capital Leases | $166M | $170M | $173M | $176M | $180M | $187M | $191M | $194M | $198M | $201M | · | $191M | $195M | $187M | · | $160M | |
| Other Non-current Liabilities | $123M | $117M | $104M | $113M | $129M | $120M | $109M | $96M | $110M | $101M | · | $62M | $73M | $67M | · | $2M | |
| Total Liabilities | $650M | $658M | $683M | $663M | $645M | $706M | $703M | $685M | $653M | $676M | · | $629M | $615M | $588M | · | $470M | |
| Common Stock | $249.0K | $254.0K | $262.0K | $268.0K | $270.0K | $275.0K | $282.0K | $286.0K | $285.0K | $295.0K | · | $311.0K | $320.0K | $325.0K | · | $323.0K | |
| Paid-in Capital | $2.11B | $2.15B | $2.23B | $2.26B | $2.25B | $2.29B | $2.34B | $2.36B | $2.32B | $2.39B | · | $2.49B | $2.53B | $2.56B | · | $2.51B | |
| Retained Earnings | $-263M | $-216M | $-77M | $-106M | $-220M | $-163M | $-99M | $-90M | $-200M | $-259M | · | $-126M | $11M | $6M | · | $-4M | |
| AOCI | $-2M | $-415.0K | $3M | $4M | $1M | $2M | $-1M | $4M | $-5M | $-5M | · | $-14M | $-14M | $-9M | · | $-18M | |
| Stockholders' Equity | $1.84B | $1.94B | $2.16B | $2.16B | $2.03B | $2.13B | $2.24B | $2.28B | $2.12B | $2.13B | $2.26B | $2.35B | $2.53B | $2.56B | $2.49B | $2.49B | |
| Liabilities + Equity | $2.49B | $2.59B | $2.84B | $2.82B | $2.68B | $2.84B | $2.95B | $2.96B | $2.77B | $2.80B | · | $2.98B | $3.14B | $3.14B | · | $2.96B | |
| Shares Outstanding | 248,885,000 | 253,701,000 | 262,483,000 | 268,098,000 | 270,132,000 | 275,033,000 | 281,732,000 | 285,780,000 | 285,222,000 | 295,032,000 | 302,793,000 | 310,970,000 | 320,253,000 | 324,985,000 | 323,951,000 | 322,541,000 |
नकदी प्रवाह 12
| मेट्रिक | रुझान | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2024 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $7M | $7M | $8M | $7M | $7M | $7M | $10M | $7M | $7M | $6M | $7M | $6M | $6M | $7M | $6M | $6M | |
| Stock-based Comp | $33M | $29M | $45M | $31M | $36M | $26M | $12M | $23M | $25M | $19M | $24M | $40M | $25M | $17M | $26M | $37M | |
| Restructuring | · | · | $-13M | $20M | $0 | $0 | $34M | $96.0K | $475.0K | $33M | · | $0 | $0 | $0 | · | · | |
| Other Non-cash | · | $5M | · | · | · | $19M | · | · | · | $6M | · | · | · | $21M | · | · | |
| Operating Cash Flow | $308M | $252M | $425M | $290M | $49M | $211M | $377M | $271M | $120M | $69M | $11M | $117M | $121M | $84M | $74M | $110M | |
| CapEx | $7M | $2M | $-16M | $1M | $3M | $3M | $1M | $8M | $7M | $10M | $13M | $9M | $6M | $12M | $10M | $43.0K | |
| Investing Cash Flow | $91M | $-51M | $374M | $25M | $248M | $50M | $-28M | $-217M | $82M | $112M | $62M | $35M | $-74M | $-50M | $-246M | $-69M | |
| Stock Repurchased | $323M | $430M | $486M | $104M | $302M | $284M | $311M | $12M | $264M | $185M | $209M | $217M | $124M | $0 | $0 | $0 | |
| Net Stock Activity | · | $-430M | · | · | · | $-284M | · | · | · | $-185M | · | · | · | · | · | · | |
| Financing Cash Flow | $-344M | $-457M | $-529M | $-104M | $-316M | $-295M | $-289M | $6M | $-262M | $-184M | $-206M | $-220M | $-125M | $5M | $-2M | $-2M | |
| Net Change in Cash | $55M | $-256M | $270M | $212M | $-19M | $-34M | $60M | $60M | $-61M | $-3M | $-134M | $-68M | $-78M | $39M | $-174M | $39M | |
| Free Cash Flow | · | $250M | · | · | · | $208M | · | · | · | $59M | · | · | · | $72M | · | · |
लाभप्रदता 5
| मेट्रिक | रुझान | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2024 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 39.5% | 41.1% | · | 39.6% | 37.6% | 33.6% | · | 25.2% | 43.3% | 6.9% | · | -3.7% | 16.6% | 7.0% | · | 20.1% | |
| Net Margin | 33.7% | 34.5% | · | 32.4% | 32.5% | 28.7% | · | 21.9% | 35.5% | 8.8% | · | 0.22% | 17.3% | 9.8% | · | 17.8% | |
| EBITDA Margin | 39.5% | 42.3% | · | 39.6% | 37.6% | 35.0% | · | 25.2% | 43.3% | 8.4% | · | -3.7% | 16.6% | 8.7% | · | 20.1% | |
| ROA | 8.2% | 7.8% | · | 6.7% | 6.8% | 5.7% | · | 4.0% | 7.6% | 1.2% | · | 0.04% | 2.7% | 1.4% | · | 2.7% | |
| ROE | 10.9% | 10.3% | · | 8.7% | 8.9% | 7.5% | · | 5.1% | 9.7% | 1.6% | · | 0.04% | 3.3% | 1.7% | · | 3.2% |
तरलता और शोधन क्षमता 2
| मेट्रिक | रुझान | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2024 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 3.3 | · | 3.8 | 3.5 | 3.5 | · | 3.9 | 4.3 | 3.5 | · | 3.8 | 4.7 | 5.0 | · | 6.1 | |
| Quick Ratio | 3.2 | 3.0 | · | 3.5 | 3.2 | 3.3 | · | 3.7 | 4.0 | 3.2 | · | 3.6 | 4.4 | 4.7 | · | 5.8 |
दक्षता 3
| मेट्रिक | रुझान | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2024 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | |
| Inventory Turnover | 0.8 | 0.8 | · | 0.8 | 0.9 | 0.8 | · | 0.8 | 0.7 | 0.8 | · | 0.7 | 0.6 | 0.5 | · | 0.6 | |
| Receivables Turnover | 2.0 | 2.0 | · | 2.1 | 1.6 | 2.1 | · | 2.1 | 2.0 | 1.8 | · | 2.0 | 2.0 | 1.9 | · | 2.1 |
मूल्यांकन (TTM) 10
| मेट्रिक | रुझान | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2024 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.41B | $2.33B | · | $2.26B | $2.30B | $2.16B | · | $2.07B | $2.00B | $1.78B | · | $1.76B | $1.71B | $1.60B | · | $1.52B | |
| Net Income TTM | $801M | $749M | · | $656M | $689M | $541M | · | $382M | $346M | $160M | · | $195M | $265M | $252M | · | $251M | |
| Market Cap | $13.90B | $11.13B | · | $10.75B | $12.47B | $9.51B | · | $7.42B | $6.41B | $7.00B | · | $6.79B | $6.12B | $6.31B | · | $5.06B | |
| P/E | 18.9 | 16.4 | · | 17.5 | 19.5 | 18.8 | · | 20.1 | 19.7 | 48.4 | · | 36.4 | 23.3 | 24.9 | · | 20.1 | |
| P/S | 5.8 | 4.8 | · | 4.8 | 5.4 | 4.4 | · | 3.6 | 3.2 | 3.9 | · | 3.9 | 3.6 | 4.0 | · | 3.3 | |
| P/B | 7.5 | 5.8 | · | 5.0 | 6.1 | 4.5 | · | 3.3 | 3.0 | 3.3 | · | 2.9 | 2.4 | 2.5 | · | 2.0 | |
| P / Tangible Book | 7.8 | 5.9 | · | 5.1 | 6.3 | 4.6 | · | 3.4 | 3.1 | 3.4 | · | 3.0 | 2.5 | 2.5 | · | 2.1 | |
| P / Cash Flow | · | 44.2 | · | · | · | 45.0 | · | · | · | 101.7 | · | · | · | 74.7 | · | · | |
| P / FCF | · | 44.5 | · | · | · | 45.6 | · | · | · | 118.4 | · | · | · | 87.1 | · | · | |
| Earnings Yield | 5.3% | 6.1% | · | 5.7% | 5.1% | 5.3% | · | 5.0% | 5.1% | 2.1% | · | 2.8% | 4.3% | 4.0% | · | 5.0% |
वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष
आय विवरण
| 2026-01-02 | 2025-01-03 | 2023-12-29 | 2022-12-30 | 2021-12-31 | |
|---|---|---|---|---|---|
| राजस्व | $2.32B | $2.17B | $1.83B | $1.61B | $1.43B |
| परिचालन मार्जिन % | 37.6% | 27.9% | 9.3% | 12.5% | 20.0% |
| शुद्ध आय | $783M | $521M | $208M | $182M | $231M |
| तनुकरणित EPS | $2.78 | $1.76 | $0.65 | $0.56 | $0.72 |
बैलेंस शीट
| 2026-01-02 | 2025-01-03 | 2023-12-29 | 2022-12-30 | 2021-12-31 | |
|---|---|---|---|---|---|
| वर्तमान अनुपात | 3.6 | 3.6 | 3.3 | 5.0 | 5.4 |
| त्वरित अनुपात | 3.3 | 3.4 | 3.1 | 4.7 | 5.2 |
नकदी प्रवाह
| 2026-01-02 | 2025-01-03 | 2023-12-29 | 2022-12-30 | 2021-12-31 | |
|---|---|---|---|---|---|
| फ्री कैश फ्लो | $876M | $672M | $293M | $335M | $337M |
ताज़ा समाचार इस कंपनी का उल्लेख करने वाली हालिया सुर्खियां
ट्रेडिंग सिग्नल प्रवेश मूल्य और जोखिम/इनाम अनुपात के साथ हालिया खरीद/बिक्री संकेत
मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ
📊
उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर पूर्ण फंडामेंटल में किसी भी पंक्ति के बगल में ➕ पर क्लिक करें।
आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।
संस्थागत मालिक (13F) 811 फाइलर्स · $9.1B कुल · तिथि अनुसार 30 जून 2026
संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।
संस्थागत गतिविधि — Q2 2026 बनाम पिछली तिमाही
| नई स्थितियाँ | बाहर निकली पोजीशन | बढ़ाया | घटा हुआ | शुद्ध शेयर परिवर्तन |
|---|---|---|---|---|
| 135 (+27 पिछली तिमाही की तुलना में) | 61 (-13 पिछली तिमाही की तुलना में) | 240 (-1 पिछली तिमाही की तुलना में) | 274 (+16 पिछली तिमाही की तुलना में) | +39.8M |
Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।
| संस्था | मूल्य | शेयर | % ट्रैक किए गए 13F का | प्रकार |
|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $732794424 | 13468010 | 8.04% | शेयर |
| RENAISSANCE TECHNOLOGIES LLC | $730617099 | 13427993 | 8.01% | शेयर |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $655266268 | 12043122 | 7.19% | शेयर |
| VANGUARD CAPITAL MANAGEMENT LLC | $595843747 | 10950997 | 6.53% | शेयर |
| STATE STREET CORP | $542471563 | 9970071 | 5.95% | शेयर |
| FULLER & THALER ASSET MANAGEMENT, INC. | $485848030 | 8929389 | 5.33% | शेयर |
| GEODE CAPITAL MANAGEMENT, LLC | $362702104 | 6664894 | 3.98% | शेयर |
| D. E. Shaw & Co., Inc. | $281389313 | 5171647 | 3.09% | शेयर |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $237550034 | 4365926 | 2.60% | शेयर |
| TWO SIGMA INVESTMENTS, LP | $229058537 | 4209861 | 2.51% | शेयर |
| DIMENSIONAL FUND ADVISORS LP | $221832835 | 4077060 | 2.43% | शेयर |
| ASSETMARK, INC | $186834364 | 3433824 | 2.05% | शेयर |
| Stephens Investment Management Group LLC | $147451698 | 2710011 | 1.62% | शेयर |
| NORGES BANK | $146301199 | 2688866 | 1.60% | शेयर |
| FIRST TRUST ADVISORS LP | $138383701 | 2543353 | 1.52% | शेयर |
| Caisse de depot et placement du Quebec | $113950809 | 2094299 | 1.25% | शेयर |
| GOLDMAN SACHS GROUP INC | $106578308 | 1958800 | 1.17% | शेयर |
| AMERICAN CENTURY COMPANIES INC | $97484439 | 1791664 | 1.07% | शेयर |
| VANGUARD FIDUCIARY TRUST CO | $86563209 | 1590943 | 0.95% | शेयर |
| Caligan Partners LP | $84512985 | 1553262 | 0.93% | शेयर |
| MILLENNIUM MANAGEMENT LLC | $66309793 | 1218706 | 0.73% | शेयर |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $63086055 | 1159457 | 0.69% | शेयर |
| BANK OF AMERICA CORP /DE/ | $58788318 | 1080469 | 0.64% | शेयर |
| Robeco Institutional Asset Management B.V. | $56032453 | 1029819 | 0.61% | शेयर |
| ENVESTNET ASSET MANAGEMENT INC | $51671488 | 949669 | 0.57% | शेयर |
| FMR LLC | $48839667 | 897623 | 0.54% | शेयर |
| Gotham Asset Management, LLC | $48569794 | 892663 | 0.53% | शेयर |
| Swedbank AB | $45801141 | 841778 | 0.50% | शेयर |
| Allspring Global Investments Holdings, LLC | $44544520 | 825510 | 0.49% | शेयर |
| Retirement Systems of Alabama | $44107739 | 810655 | 0.48% | शेयर |
| BOOTHBAY FUND MANAGEMENT, LLC | $43750809 | 804095 | 0.48% | शेयर |
| RAYMOND JAMES FINANCIAL INC | $41924320 | 770526 | 0.46% | शेयर |
| Capital Impact Advisors, LLC | $41061268 | 754664 | 0.45% | शेयर |
| BlackRock, Inc. | $40753525 | 749008 | 0.45% | शेयर |
| RHUMBLINE ADVISERS | $35723294 | 656559 | 0.39% | शेयर |
| CANADA PENSION PLAN INVESTMENT BOARD | $35464438 | 651800 | 0.39% | शेयर |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $34721830 | 639680 | 0.38% | शेयर |
| MARSHALL WACE, LLP | $34322590 | 630814 | 0.38% | शेयर |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | $34315027 | 630675 | 0.38% | शेयर |
| AMERIPRISE FINANCIAL INC | $32255716 | 592827 | 0.35% | शेयर |
| BARCLAYS PLC | $31502574 | 578985 | 0.35% | शेयर |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $31496480 | 578873 | 0.35% | शेयर |
| Arbejdsmarkedets Tillaegspension | $30855911 | 567100 | 0.34% | शेयर |
| Pictet Asset Management Holding SA | $30153926 | 555438 | 0.33% | शेयर |
| California Public Employees Retirement System | $29366600 | 539728 | 0.32% | शेयर |
| CAPITAL FUND MANAGEMENT S.A. | $28686856 | 527235 | 0.31% | शेयर |
| BNP PARIBAS FINANCIAL MARKETS | $28655734 | 526663 | 0.31% | शेयर |
| JANUS HENDERSON GROUP PLC | $26675806 | 621814 | 0.29% | शेयर |
| Woodline Partners LP | $26411049 | 485408 | 0.29% | शेयर |
| Driehaus Capital Management LLC | $26025500 | 478322 | 0.29% | शेयर |
| EULAV Asset Management | $25901500 | 476043 | 0.28% | शेयर |
| Squarepoint Ops LLC | $25774398 | 473707 | 0.28% | शेयर |
| Swiss National Bank | $25648874 | 471400 | 0.28% | शेयर |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $25156355 | 462348 | 0.28% | शेयर |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $24600555 | 452133 | 0.27% | शेयर |
| IEQ CAPITAL, LLC | $24580697 | 451768 | 0.27% | शेयर |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $23831580 | 438000 | 0.26% | शेयर |
| Baird Financial Group, Inc. | $23565461 | 433109 | 0.26% | शेयर |
| FRANKLIN RESOURCES INC | $23480472 | 431547 | 0.26% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $23347331 | 429100 | 0.26% | कॉल ऑप्शन |
| Assenagon Asset Management S.A. | $23324098 | 428673 | 0.26% | शेयर |
| BANK OF NOVA SCOTIA | $22837676 | 419730 | 0.25% | शेयर |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $22615516 | 415650 | 0.25% | शेयर |
| South Street Advisors LLC | $22275019 | 409392 | 0.24% | शेयर |
| Bridgewater Associates, LP | $21810738 | 400859 | 0.24% | शेयर |
| VICTORY CAPITAL MANAGEMENT INC | $21480143 | 394783 | 0.24% | शेयर |
| ROYAL BANK OF CANADA | $20031000 | 368153 | 0.22% | शेयर |
| SEI INVESTMENTS CO | $19897640 | 365698 | 0.22% | शेयर |
| LAZARD ASSET MANAGEMENT LLC | $18664208 | 343029 | 0.20% | शेयर |
| Nuveen, LLC | $18299226 | 336321 | 0.20% | शेयर |
| Nuveen Asset Management, LLC | $18252629 | 548127 | 0.20% | शेयर |
| NFJ INVESTMENT GROUP, LLC | $17880160 | 328619 | 0.20% | शेयर |
| SAWGRASS ASSET MANAGEMENT LLC | $17808447 | 327301 | 0.20% | शेयर |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $17565616 | 322838 | 0.19% | शेयर |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $17472485 | 407379 | 0.19% | शेयर |
| ING GROEP NV | $16943274 | 311400 | 0.19% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $16529758 | 303800 | 0.18% | पुट ऑप्शन |
| Brandywine Global Investment Management, LLC | $16490117 | 376229 | 0.18% | शेयर |
| CAPTRUST FINANCIAL ADVISORS | $16488532 | 303042 | 0.18% | शेयर |
| INTECH INVESTMENT MANAGEMENT LLC | $16262224 | 298883 | 0.18% | शेयर |
| HighTower Advisors, LLC | $15842121 | 291162 | 0.17% | शेयर |
| SEIZERT CAPITAL PARTNERS, LLC | $15411796 | 283253 | 0.17% | शेयर |
| Trexquant Investment LP | $14974122 | 275209 | 0.16% | शेयर |
| Clark Capital Management Group, Inc. | $14792882 | 271878 | 0.16% | शेयर |
| ALLIANCEBERNSTEIN L.P. | $14763381 | 344215 | 0.16% | शेयर |
| VAN ECK ASSOCIATES CORP | $14270709 | 262281 | 0.16% | शेयर |
| GLOBEFLEX CAPITAL L P | $13874169 | 254993 | 0.15% | शेयर |
| Sofinnova Investments, Inc. | $13831022 | 254200 | 0.15% | पुट ऑप्शन |
| JANE STREET GROUP, LLC | $13815570 | 253916 | 0.15% | शेयर |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $13724052 | 252234 | 0.15% | शेयर |
| Voleon Capital Management LP | $13682047 | 251462 | 0.15% | शेयर |
| BLAIR WILLIAM & CO/IL | $13233352 | 243215 | 0.15% | शेयर |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $13027000 | 239418 | 0.14% | शेयर |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $12745021 | 297156 | 0.14% | शेयर |
| MERITAGE PORTFOLIO MANAGEMENT | $12679099 | 289279 | 0.14% | शेयर |
| VANGUARD ASSET MANAGEMENT, Ltd | $12516694 | 230044 | 0.14% | शेयर |
| Susquehanna Portfolio Strategies, LLC | $12500643 | 229749 | 0.14% | शेयर |
| MILLENNIUM MANAGEMENT LLC | $12035492 | 221200 | 0.13% | कॉल ऑप्शन |
| Illinois Municipal Retirement Fund | $11750764 | 215967 | 0.13% | शेयर |
| CWM, LLC | $11300486 | 263476 | 0.12% | शेयर |
कंपनी के अंदरूनी सूत्र 43 इनसाइडर्स · 22 अधिकारी · 10 निदेशक
| अंदरूनी | भूमिका | अंतिम गतिविधि | शेयरों का स्वामित्व | खरीद 12m | बिक्री 12m | नेट 12m |
|---|---|---|---|---|---|---|
| Michael Morrissey | President and CEO | 18 मई 2026 G | 2004327 | 0 | 0 | $0 |
| Christopher J. Senner | EVP and CFO | 18 मई 2026 S | 952317 | 0 | 3 | $-4556048 |
| Deborah Burke | SVP & Chief Financial Officer | 15 नवमबर 2014 M | 18156 | 0 | 0 | $0 |
| Frank Karbe | EVP and CFO | 15 फ़रवरी 2014 M | 93990 | 0 | 0 | $0 |
| Kristine M Ball | Controller & Interim CFO | 10 दिसमबर 2003 A | 4913 | 0 | 0 | $0 |
| Patrick J. Haley | EVP, Commercial | 20 मई 2026 S | 357638 | 0 | 7 | $-7597268 |
| Brenda Hefti | SVP and General Counsel | 18 मई 2026 S | 106762 | 0 | 2 | $-1154264 |
| Amy C. Peterson | EVP Prod Dev & Med Aff & CMO | 16 मई 2025 M | 465393 | 0 | 0 | $0 |
| Jeffrey Hessekiel | EVP & General Counsel | 15 मई 2025 S | 693396 | 0 | 0 | $0 |
| Vicki L Goodman | EVP, Prod Dev & Med Aff &CMO | 3 अप्रैल 2023 A | 307654 | 0 | 0 | $0 |
| Peter Lamb | EVP, Scientific Strategy & CSO | 15 दिसमबर 2022 M | 410958 | 0 | 0 | $0 |
| Gisela Schwab | Pres, Prod Dev & Med Aff & CMO | 26 जुलाई 2021 M | 689078 | 0 | 0 | $0 |
| Pamela A Simonton | EVP and General Counsel | 15 नवमबर 2013 M | 17139 | 0 | 0 | $0 |
| Lupe M Rivera | EVP, Operations | 15 अगस्त 2011 M | 19219 | 0 | 0 | $0 |
| Frances K Heller | EVP, Business Development | 15 मई 2011 M | 17125 | 0 | 0 | $0 |
| Ian D Malcolm | VP, STRATEGIC MARKETING | 8 दिसमबर 2006 A | — | 0 | 0 | $0 |
| Christoph Pereira | VP, Legal Affairs & Secretary | 8 दिसमबर 2006 A | — | 0 | 0 | $0 |
| Jeffrey Latts | Executive VP, Development | 8 दिसमबर 2006 A | — | 0 | 0 | $0 |
| Gregory Plowman | Sr VP, CSO | 13 दिसमबर 2004 A | — | 0 | 0 | $0 |
| Steven P James | Sr VP, Commercial Ops | 10 दिसमबर 2003 A | — | 0 | 0 | $0 |
| Jane M Green | VP, Corp Communications | 10 दिसमबर 2003 A | — | 0 | 0 | $0 |
| Geoffrey M Duyk | Pres R&D & CSO | 4 नवमबर 2003 S | 941355 | 0 | 0 | $0 |
| Alan M Garber | निदेशक | 21 मार्च 2024 M | 35703 | 0 | 0 | $0 |
| Jacqueline Wright | निदेशक | 1 जून 2023 A | 51756 | 0 | 0 | $0 |
| Carl B Feldbaum | निदेशक | 9 फ़रवरी 2023 M | 18701 | 0 | 0 | $0 |
| Lance Willsey | निदेशक | 26 मई 2022 A | 424415 | 0 | 0 | $0 |
| Vincent T Marchesi | निदेशक | 26 मई 2022 A | 93989 | 0 | 0 | $0 |
| Charles Cohen | निदेशक | 6 जुलाई 2021 M | 261375 | 0 | 0 | $0 |
| George A Scangos | निदेशक | 18 मई 2020 S | 714717 | 0 | 0 | $0 |
| FORMELA JEAN FRANCOIS | निदेशक | 7 सितमबर 2005 S | 584519 | 0 | 0 | $0 |
| Mary C Beckerle | — | 10 अगस्त 2026 S | 16079 | 0 | 4 | $-1932572 |
| Sue Gail Eckhardt | — | 1 जून 2026 S | 16079 | 0 | 2 | $-660828 |
| Jack L Wyszomierski | — | 1 जून 2026 S | 284384 | 0 | 2 | $-4580661 |
| Tomas J. Heyman | — | 27 मई 2026 A | 50649 | 0 | 0 | $0 |
| Bob Oliver | — | 27 मई 2026 A | 29487 | 0 | 2 | $-1325340 |
| Julie Smith | — | 27 मई 2026 A | 28957 | 0 | 3 | $-4687346 |
| Maria C Freire | — | 27 मई 2026 A | 109186 | 0 | 1 | $-949164 |
| Stelios Papadopoulos | — | 27 मई 2026 A | 1197595 | 0 | 1 | $-4355000 |
| George Poste | — | 27 मई 2026 A | 127199 | 0 | 1 | $-2742600 |
| Dana Aftab | — | 26 मई 2026 S | 594741 | 0 | 4 | $-7701255 |
| Frank Mccormick | — | 6 दिसमबर 2013 A | — | 0 | 0 | $0 |
| Scott J. Garland | — | 18 सितमबर 2013 A | — | 0 | 0 | $0 |
| Jason S Fisherman | — | 8 सितमबर 2005 S | 7881 | 0 | 0 | $0 |
SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S
कार्यकर्ता और 5%+ मालिक 4 होल्डिंग्स
जिन निवेशकों ने SEC शेड्यूल 13D दाखिल किया है — जारीकर्ता को प्रभावित करने के इरादे से 5% से अधिक लाभकारी स्वामित्व (कार्यकर्ता दांव, बोर्ड अभियान, M&A)। प्रत्येक पंक्ति उस फाइलर की स्थिति की सबसे हालिया ज्ञात स्थिति दिखाती है।
| फाइलर | दाखिल किया | दांव | स्थिति | उद्देश्य | फाइलिंग |
|---|---|---|---|---|---|
| Farallon Capital Management, L.L.C., Farallon Capital Partners, L.P., Farallon Capital Institutional Partners, L.P., Farallon Capital Institutional Partners II, L.P., Farallon Capital Institutional Partners III, L.P., Four Crossings Institutional Partners V, L.P., Farallon Capital Offshore Investors II, L.P., Farallon Capital (AM) Investors, L.P., Farallon Capital F5 Master I, L.P., Farallon Healthcare Partners Master, L.P., Farallon Partners, L.L.C., Farallon Institutional (GP) V, L.L.C., Farallon F5 (GP), L.L.C., Farallon Healthcare Partners (GP), L.L.C., Dapice Joshua J., Dreyfuss, Philip D., Dunn Hannah E., Gehani, Varun N., Giauque, Nicolas, Husen, Avner A., Kim, David T., Linn, Michael G., Luo Patrick (Cheng), Roberts, Jr., Thomas G., Saito Edric C., Short Daniel S., Spokes, Andrew J. M., Warren, John R., Wehrly, Mark C. | 14 अगस्त 2026 | 5.60% | संशोधन | — | SEC |
| Farallon Capital Partners, L.P., Farallon Capital Institutional Partners, L.P., Farallon Capital Institutional Partners II, L.P., Farallon Capital Institutional Partners III, L.P., Four Crossings Institutional Partners V, L.P., Farallon Capital Offshore Investors II, L.P., Farallon Capital (AM) Investors, L.P., Farallon Capital F5 Master I, L.P., Farallon Healthcare Partners Master, L.P., Farallon Partners, L.L.C., Farallon Institutional (GP) V, L.L.C., Farallon F5 (GP), L.L.C., Farallon Healthcare Partners (GP), L.L.C., Dapice Joshua J., Dreyfuss, Philip D., Dunn Hannah E., Fried, Richard B, Gehani, Varun N., Giauque, Nicolas, Husen, Avner A., Kim, David T., Linn, Michael G., Luo Patrick (Cheng), Patel, Rajiv A., Roberts, Jr., Thomas G., Saito Edric C., Seybold, William, Short Daniel S., Spokes, Andrew J. M., Warren, John R., Wehrly, Mark C. ×8 फाइलिंग | 5 जनवरी 2026 | 5.90% | संशोधन | — | SEC |
| Caligan Partners LP, David Johnson ×3 फाइलिंग | 2 जून 2023 | — | प्रारंभिक फाइलिंग | — | SEC |
| अघोषित रिपोर्टिंग व्यक्ति | 29 नवमबर 2001 | — | प्रारंभिक फाइलिंग | M&A / बिक्री | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ईटीएफ स्वामित्व 152 ETFs द्वारा धारित
वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।
| फंड | भार | इकाइयाँ | तिथि अनुसार | स्रोत |
|---|---|---|---|---|
| IDNA · iShares Trust | 3.47% | 131275 SH | 8 अगस्त 2026 | दैनिक |
| SAWG · ETF Series Solutions | 2.82% | 1599 NS | 30 अप्रैल 2026 | N-PORT |
| CANC · Tema ETF Trust | 2.78% | 96885 NS | 31 मई 2026 | N-PORT |
| XMHQ · Invesco Exchange-Traded Fund Trust | 2.67% | 2774135 SH | 8 अगस्त 2026 | दैनिक |
| PBE · Invesco Exchange-Traded Fund Trust | 2.59% | 173519 SH | 8 अगस्त 2026 | दैनिक |
| MCOW · Pacer Funds Trust | 2.38% | 528 NS | 30 अप्रैल 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2.24% | 441186 NS | 30 अप्रैल 2026 | N-PORT |
| LYLD · Cambria ETF Trust | 2.01% | 2722 NS | 30 अप्रैल 2026 | N-PORT |
| AZTD · Tidal Trust I | 1.92% | 18950 NS | 30 अप्रैल 2026 | N-PORT |
| GRPM · Invesco Exchange-Traded Fund Trust | 1.84% | 172947 SH | 8 अगस्त 2026 | दैनिक |
| BBP · ETFis Series Trust I | 1.74% | 23148 NS | 30 अप्रैल 2026 | N-PORT |
| ABOT · Abacus FCF ETF Trust | 1.61% | 1596 NS | 30 अप्रैल 2026 | N-PORT |
| BUL · Pacer Funds Trust | 1.45% | 41520 NS | 30 अप्रैल 2026 | N-PORT |
| JSMD · Janus Detroit Street Trust | 1.39% | 306870 NS | 30 अप्रैल 2026 | N-PORT |
| JMID · Janus Detroit Street Trust | 1.36% | 5563 NS | 30 अप्रैल 2026 | N-PORT |
| RFG · Invesco Exchange-Traded Fund Trust | 1.30% | 86397 SH | 8 अगस्त 2026 | दैनिक |
| PTH · Invesco Exchange-Traded Fund Trust | 1.29% | 58887 SH | 8 अगस्त 2026 | दैनिक |
| COWG · Pacer Funds Trust | 1.26% | 616432 NS | 30 अप्रैल 2026 | N-PORT |
| TAX · EA Series Trust | 1.13% | 5692 NS | 29 मई 2026 | N-PORT |
| CALF · Pacer Funds Trust | 1.07% | 829382 NS | 30 अप्रैल 2026 | N-PORT |
| AFMC · First Trust Exchange-Traded Fund VI… | 1.03% | 32938 NS | 31 मई 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 1.00% | 116281 NS | 30 अप्रैल 2026 | N-PORT |
| IBB · iShares Trust | 0.98% | 1788613 SH | 8 अगस्त 2026 | दैनिक |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.93% | 13681 SH | 8 अगस्त 2026 | दैनिक |
| AGNG · Global X Funds | 0.92% | 14988 NS | 31 मई 2026 | N-PORT |
| OASC · Unified Series Trust | 0.91% | 15171 NS | 31 मई 2026 | N-PORT |
| SMDX · Tidal Trust III | 0.90% | 25550 NS | 30 अप्रैल 2026 | N-PORT |
| FLOW · Global X Funds | 0.90% | 5093 NS | 31 मई 2026 | N-PORT |
| VAMO · Cambria ETF Trust | 0.88% | 16470 NS | 30 अप्रैल 2026 | N-PORT |
| IVOG · VANGUARD ADMIRAL FUNDS | 0.72% | 248016 SH | 8 अगस्त 2026 | दैनिक |
| FLRG · FIDELITY COVINGTON TRUST | 0.72% | 45672 NS | 30 अप्रैल 2026 | N-PORT |
| IJK · iShares Trust | 0.70% | 1469020 SH | 8 अगस्त 2026 | दैनिक |
| MMSC · First Trust Exchange-Traded Fund VI… | 0.69% | 7149 NS | 31 मई 2026 | N-PORT |
| CLSE · Trust for Professional Managers | 0.68% | 82717 NS | 31 मई 2026 | N-PORT |
| BIB · ProShares Trust | 0.66% | 9600 NS | 31 मई 2026 | N-PORT |
| TMFX · RBB Fund, Inc. | 0.64% | 4091 NS | 31 मई 2026 | N-PORT |
| VUSE · ETF Series Solutions | 0.63% | 85930 NS | 31 मई 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 0.60% | 2080 NS | 30 अप्रैल 2026 | N-PORT |
| PDP · Invesco Exchange-Traded Fund Trust | 0.59% | 165207 SH | 8 अगस्त 2026 | दैनिक |
| QGRO · AMERICAN CENTURY ETF TRUST | 0.58% | 255026 NS | 31 मई 2026 | N-PORT |
| SIXL · EXCHANGE TRADED CONCEPTS TRUST | 0.53% | 19762 NS | 31 मई 2026 | N-PORT |
| VLLU · Harbor ETF Trust | 0.51% | 502 NS | 30 अप्रैल 2026 | N-PORT |
| VFQY · VANGUARD WELLINGTON FUND | 0.49% | 42746 SH | 8 अगस्त 2026 | दैनिक |
| LSVD · ADVISORS' INNER CIRCLE FUND | 0.48% | 64828 NS | 30 अप्रैल 2026 | N-PORT |
| HQGO · Lattice Strategies Trust | 0.47% | 5095 NS | 30 अप्रैल 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0.45% | 147282 SH | 8 अगस्त 2026 | दैनिक |
| IQSM · New York Life Investments ETF Trust | 0.44% | 30864 NS | 30 अप्रैल 2026 | N-PORT |
| XJH · iShares Trust | 0.41% | 33981 SH | 8 अगस्त 2026 | दैनिक |
| FNY · First Trust Exchange-Traded AlphaDE… | 0.41% | 47960 NS | 30 अप्रैल 2026 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0.41% | 33169 SH | 8 अगस्त 2026 | दैनिक |